Bill Few Associates
ABBV icon

Bill Few Associates’s AbbVie ABBV Stock Holding History

Bill Few Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.42M Sell
36,024
-2,597
-7% -$666K 1.94% 8
2026
Q2 		$9.7M Sell
38,621
-3,989
-9% -$858K 2.07% 8
2026
Q1 		$9.27M Buy
42,610
+727
+2% +$161K 2.22% 8
2025
Q4 		$9.6M Buy
41,883
+7,805
+23% +$1.78M 2.35% 7
2025
Q3 		$7.89M Buy
34,078
+349
+1% +$71.1K 2.03% 9
2025
Q2 		$6.26M Sell
33,729
-1,052
-3% -$196K 1.77% 9
2025
Q1 		$7.29M Sell
34,781
-34
-0.1% -$6.61K 2.6% 5
2024
Q4 		$6.19M Buy
34,815
+481
+1% +$88.4K 2.17% 8
2024
Q3 		$6.78M Buy
34,334
+43
+0.1% +$8.02K 2.41% 6
2024
Q2 		$5.88M Sell
34,291
-390
-1% -$64.6K 2.26% 8
2024
Q1 		$6.32M Buy
34,681
+558
+2% +$96.2K 2.56% 5
2023
Q4 		$5.29M Sell
34,123
-396
-1% -$57.7K 2.41% 7
2023
Q3 		$5.15M Buy
34,519
+474
+1% +$69.6K 2.69% 7
2023
Q2 		$4.59M Sell
34,045
-486
-1% -$71.3K 2.37% 10
2023
Q1 		$5.5M Buy
34,531
+465
+1% +$71.1K 3.06% 3
2022
Q4 		$5.51M Sell
34,066
-259
-0.8% -$39.7K 3.25% 4
2022
Q3 		$4.61M Sell
34,325
-2,327
-6% -$334K 3.12% 4
2022
Q2 		$5.61M Sell
36,652
-733
-2% -$112K 3.59% 3
2022
Q1 		$6.06M Buy
37,385
+125
+0.3% +$18.2K 3.3% 3
2021
Q4 		$5.04M Buy
+37,260
New +$4.4M 2.61% 7

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Bill Few Associates's ABBV Position: Q3 2026 in Review

Bill Few Associates reduced its AbbVie (ABBV) stake by 6.7% in Q3 2026, selling an estimated $666K and leaving 36,024 shares worth $9.42M. The position accounts for 1.94% of the portfolio, ranked #8.

Bill Few Associates first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $9.7M in Q2 2026. 1,792 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Bill Few Associates held 36,024 shares of AbbVie worth $9.42M as of Q3 2026.
  • Bill Few Associates sold 2,597 AbbVie shares in Q3 2026, an estimated $666K.
  • AbbVie made up 1.94% of Bill Few Associates's portfolio in Q3 2026, its #8 holding.
  • Bill Few Associates first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
  • Bill Few Associates's AbbVie position peaked at $9.7M in Q2 2026.
  • 1,792 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.